Based on our data, we suggest that CPN2, FXII, PLG, MASP1, APCS, PON1, and CA1 for IS and FBLN1 and GRN for ICH should be further scientifically pursued as potential stroke blood biomarkers. The gene discussed is GRN; the disease is stroke disorder.